Refractory, chronic phase Chronic myeloid leukemia
Also known as: Refractory chronic phase Chronic myeloid leukemia
Drug | Drug Name | Drug Description |
---|---|---|
DB00619 | Imatinib | A tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors. |
DB04865 | Omacetaxine mepesuccinate | A cephalotaxine used in the treatment of Chronic Myeloid Leukemia (CML) that is intolerant to or resistant to two or more tyrosine kinase inhibitors. |
Drug | Drug Name | Phase | Status | Count |
---|